BioWorld MedTech

July 14, 2016

View Archived Issues

Feds request additional information about Abbott's $25 billion merger with St. Jude, putting possible divestments in the cards

The U.S. Federal Trade Commission requested more information about the impending $25 billion merger of St. Jude Medical Inc. and Abbott Laboratories, meaning the earliest date at which the deal can close has been extended by 30 days. Read More

China's PMI moving forward; NHFPC names 61 projects for funding

Read More

Resilia to team up with South African distributor to market Uresta device

Read More

Clearbridge, Cambridge partner to birth, nurture Asian startup companies

Read More

Patients deserve a stronger voice in clinical trial design

Read More

Other news to note

Read More

Financings

Read More

Daily M&A

Read More

Product briefs

Read More

MDD's Orthopedics

Read More